Active treatment for food allergy.

Area of Science:

• Immunology
• Allergy Research
• Pediatric Health

Background:

• Food allergy prevalence is increasing globally, affecting a significant portion of adults and children.
• Current management relies on food avoidance and emergency treatments like epinephrine, with no FDA-approved curative therapies.
• The rising incidence necessitates novel therapeutic and preventive strategies.

Purpose of the Study:

• To review current and emerging treatment options for food allergy.
• To explore the potential of various immunotherapies and adjuvant therapies.
• To discuss the role of active prevention in mitigating food allergy sensitization.

Main Methods:

• Review of recent clinical studies and research on food allergy treatments.
• Analysis of efficacy and safety data for oral, sublingual, and epicutaneous immunotherapy.
• Examination of adjunctive therapies including bacterial adjuvants, anti-IgE antibodies, and herbal formulations.

Main Results:

• Immunotherapy (oral, sublingual, epicutaneous) shows promise for desensitizing patients, though further Phase 3 studies are needed.
• Adjunctive therapies may enhance immunotherapy effectiveness or offer alternative treatment avenues.
• Early introduction of foods in high-risk infants is emerging as a key preventive strategy.

Conclusions:

• Food allergy management is evolving beyond avoidance, with immunotherapy becoming a viable therapeutic option.
• Future treatments may involve combination therapies and personalized approaches.
• Active prevention through early dietary intervention is crucial for curbing the growing epidemic of food allergies.